8月7日工银医疗保健股票净值下跌2.03%，近1个月累计上涨10.32%

Group 1 - The core point of the news is the performance and holdings of the Industrial and Commercial Bank of China (ICBC) Healthcare Stock Fund, which has shown significant returns over various time frames despite a recent decline in net value [1] - As of August 7, 2025, the fund's latest net value is 2.8960 yuan, reflecting a decrease of 2.03%. The fund has achieved a return of 10.32% over the past month, ranking 242 out of 1022 in its category. Over the last six months, the return is 26.13%, ranking 113 out of 985, and since the beginning of the year, the return is 27.07%, ranking 155 out of 975 [1] - The top ten holdings of the ICBC Healthcare Stock Fund account for a total of 44.59%, with significant positions in companies such as Heng Rui Medicine (7.52%), Kelun Pharmaceutical (6.50%), and BeiGene (5.08%) [1] Group 2 - The ICBC Healthcare Stock Fund was established on November 18, 2014, and as of June 30, 2025, it has a total scale of 2.797 billion yuan. The fund is managed by Zhao Bei and Ding Yang [1] - Zhao Bei holds a master's degree and has extensive experience in healthcare investment, having been with ICBC Credit Suisse since 2010 and managing the healthcare fund since its inception [2] - Ding Yang, a PhD holder, joined ICBC Credit Suisse in December 2017 and has been involved in managing various funds, including the healthcare sector since May 2023 [2]